These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25136078)

  • 1. Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes.
    Cogle CR; Wise E; Meacham AM; Zierold C; Traverse JH; Henry TD; Perin EC; Willerson JT; Ellis SG; Carlson M; Zhao DX; Bolli R; Cooke JP; Anwaruddin S; Bhatnagar A; da Graca Cabreira-Hansen M; Grant MB; Lai D; Moyé L; Ebert RF; Olson RE; Sayre SL; Schulman IH; Bosse RC; Scott EW; Simari RD; Pepine CJ; Taylor DA;
    Circ Res; 2014 Oct; 115(10):867-74. PubMed ID: 25136078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letter regarding the article, "a detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes".
    Gremmels H; Papazova DA; Fledderus JO; Verhaar MC
    Circ Res; 2014 Dec; 115(12):e35. PubMed ID: 25477486
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to letter regarding article, "a detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b and clonogenic capacity as biomarkers for clinical outcomes".
    Cogle CR
    Circ Res; 2014 Dec; 115(12):e36-7. PubMed ID: 25477487
    [No Abstract]   [Full Text] [Related]  

  • 4. Stem cell in the rough: repair quotient mined out of a bone marrow niche.
    Behfar A; Terzic A
    Circ Res; 2014 Oct; 115(10):814-6. PubMed ID: 25342767
    [No Abstract]   [Full Text] [Related]  

  • 5. Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial.
    Bhatnagar A; Bolli R; Johnstone BH; Traverse JH; Henry TD; Pepine CJ; Willerson JT; Perin EC; Ellis SG; Zhao DX; Yang PC; Cooke JP; Schutt RC; Trachtenberg BH; Orozco A; Resende M; Ebert RF; Sayre SL; Simari RD; Moyé L; Cogle CR; Taylor DA;
    Am Heart J; 2016 Sep; 179():142-50. PubMed ID: 27595689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral Blood Cytokine Levels After Acute Myocardial Infarction: IL-1β- and IL-6-Related Impairment of Bone Marrow Function.
    Shahrivari M; Wise E; Resende M; Shuster JJ; Zhang J; Bolli R; Cooke JP; Hare JM; Henry TD; Khan A; Taylor DA; Traverse JH; Yang PC; Pepine CJ; Cogle CR;
    Circ Res; 2017 Jun; 120(12):1947-1957. PubMed ID: 28490433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved mobilization of the CD34(+) and CD133(+) bone marrow-derived circulating progenitor cells by freshly isolated intracoronary bone marrow cell transplantation in patients with ischemic heart disease.
    Turan RG; Bozdag-Turan I; Ortak J; Akin I; Kische S; Schneider H; Turan CH; Rehders TC; Rauchhaus M; Kleinfeldt T; Adolph E; Brehm M; Yokus S; Steiner S; Sahin K; Nienaber CA; Ince H
    Stem Cells Dev; 2011 Sep; 20(9):1491-501. PubMed ID: 21190450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between the frequency of CD34⁺ bone marrow derived circulating progenitor cells and the number of diseased coronary arteries in patients with myocardial ischemia and diabetes.
    Bozdag-Turan I; Turan RG; Turan CH; Ludovicy S; Akin I; Kische S; Arsoy NS; Schneider H; Ortak J; Rehders T; Hermann T; Paranskaya L; Kohlschein P; Bastian M; Ulus AT; Sahin K; Ince H; Nienaber CA
    Cardiovasc Diabetol; 2011 Nov; 10():107. PubMed ID: 22118372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing spontaneous mobilization of CD34+ and CD133+ progenitor cells after myocardial infarction.
    Turan RG; Brehm M; Koestering M; Tobias Z; Bartsch T; Steiner S; Picard F; Ebner P; Schannwell CM; Strauer BE
    Eur J Clin Invest; 2007 Nov; 37(11):842-51. PubMed ID: 17973780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Bone Marrow Cell Subpopulations Associated With Improved Functional Outcomes in Patients With Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN Trial.
    Taylor DA; Perin EC; Willerson JT; Zierold C; Resende M; Carlson M; Nestor B; Wise E; Orozco A; Pepine CJ; Henry TD; Ellis SG; Zhao DX; Traverse JH; Cooke JP; Schutt RC; Bhatnagar A; Grant MB; Lai D; Johnstone BH; Sayre SL; Moyé L; Ebert RF; Bolli R; Simari RD; Cogle CR;
    Cell Transplant; 2016; 25(9):1675-1687. PubMed ID: 26590374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial.
    Tendera M; Wojakowski W; Ruzyłło W; Chojnowska L; Kepka C; Tracz W; Musiałek P; Piwowarska W; Nessler J; Buszman P; Grajek S; Breborowicz P; Majka M; Ratajczak MZ;
    Eur Heart J; 2009 Jun; 30(11):1313-21. PubMed ID: 19208649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.
    Heeschen C; Lehmann R; Honold J; Assmus B; Aicher A; Walter DH; Martin H; Zeiher AM; Dimmeler S
    Circulation; 2004 Apr; 109(13):1615-22. PubMed ID: 15037527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of exercise training on mobilization of BM-CPCs and migratory capacity as well as LVEF after AMI].
    Turan RG; Brehm M; Köstering M; Bartsch T; Zeus T; Picard F; Steiner S; Fleissner T; Ilousis D; Augusta K; Kister M; Rüttger C; Schannwell CM; Strauer BE
    Med Klin (Munich); 2006 Mar; 101 Suppl 1():198-201. PubMed ID: 16802555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved functional activity of bone marrow derived circulating progenitor cells after intra coronary freshly isolated bone marrow cells transplantation in patients with ischemic heart disease.
    Turan RG; Bozdag-T I; Ortak J; Kische S; Akin I; Schneider H; Turan CH; Rehders TC; Rauchhaus M; Kleinfeldt T; Belu C; Brehm M; Yokus S; Steiner S; Sahin K; Nienaber CA; Ince H
    Stem Cell Rev Rep; 2011 Sep; 7(3):646-56. PubMed ID: 21188654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function.
    Leone AM; Rutella S; Bonanno G; Abbate A; Rebuzzi AG; Giovannini S; Lombardi M; Galiuto L; Liuzzo G; Andreotti F; Lanza GA; Contemi AM; Leone G; Crea F
    Eur Heart J; 2005 Jun; 26(12):1196-204. PubMed ID: 15734770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial.
    Roncalli J; Mouquet F; Piot C; Trochu JN; Le Corvoisier P; Neuder Y; Le Tourneau T; Agostini D; Gaxotte V; Sportouch C; Galinier M; Crochet D; Teiger E; Richard MJ; Polge AS; Beregi JP; Manrique A; Carrie D; Susen S; Klein B; Parini A; Lamirault G; Croisille P; Rouard H; Bourin P; Nguyen JM; Delasalle B; Vanzetto G; Van Belle E; Lemarchand P
    Eur Heart J; 2011 Jul; 32(14):1748-57. PubMed ID: 21127322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure.
    Kissel CK; Lehmann R; Assmus B; Aicher A; Honold J; Fischer-Rasokat U; Heeschen C; Spyridopoulos I; Dimmeler S; Zeiher AM
    J Am Coll Cardiol; 2007 Jun; 49(24):2341-9. PubMed ID: 17572250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of age, disease state, and granulocyte colony-stimulating factor on progenitor cell count and function in patients undergoing cell therapy for cardiac disease.
    Mozid AM; Jones D; Arnous S; Saunders N; Wragg A; Martin J; Agrawal S; Mathur A
    Stem Cells Dev; 2013 Jan; 22(2):216-23. PubMed ID: 22834565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function.
    Sürder D; Manka R; Lo Cicero V; Moccetti T; Rufibach K; Soncin S; Turchetto L; Radrizzani M; Astori G; Schwitter J; Erne P; Zuber M; Auf der Maur C; Jamshidi P; Gaemperli O; Windecker S; Moschovitis A; Wahl A; Bühler I; Wyss C; Kozerke S; Landmesser U; Lüscher TF; Corti R
    Circulation; 2013 May; 127(19):1968-79. PubMed ID: 23596006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intracoronary bone marrow-derived mononuclear cell injection early and late after myocardial infarction on CMR-derived myocardial strain.
    Gastl M; Sürder D; Corti R; Faruque Osmany DMM; Gotschy A; von Spizcak J; Sokolska J; Metzen D; Alkadhi H; Ruschitzka F; Kozerke S; Manka R
    Int J Cardiol; 2020 Jul; 310():108-115. PubMed ID: 31982162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.